Old Web
English
Sign In
Acemap
>
authorDetail
>
Maike H.M. Wientjes
Maike H.M. Wientjes
Rheumatoid arthritis
Adalimumab
Medicine
Internal medicine
Physical therapy
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial.
2021
Trials
Maike H.M. Wientjes
Sadaf Atiqi
Gerrit Jan Wolbink
Michael T. Nurmohamed
Maarten Boers
Theo Rispens
Annick de Vries
Ronald F. van Vollenhoven
Bart J. F. van den Bemt
Alfons A. den Broeder
Show All
Source
Cite
Save
Citations (1)
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD.
2020
Annals of the Rheumatic Diseases
Evy Ulijn
Nathan den Broeder
Maike H.M. Wientjes
Noortje van Herwaarden
Inger L. Meek
L Tweehuysen
Aatke van der Maas
Bart J. F. van den Bemt
Alfons A. den Broeder
Show All
Source
Cite
Save
Citations (3)
1